Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Gross Profit | 1,160 | 1,900 | 1,560 | 1,490 | 1,070 |
| Operating Expenses | 1,740 | 1,360 | 730 | 1,120 | 600 |
| Operating Income | -1,740 | -1,360 | -730 | -1,120 | -600 |
| Pre-tax Income | -1,740 | -1,360 | -730 | -1,120 | -600 |
| Net Income Continuous | -1,740 | -1,360 | -730 | -1,120 | -600 |
| Net Income | $-1,740 | $-1,360 | $-730 | $-1,120 | $-600 |
| EBITDA(a) | $-1,480 | $-1,100 | $-450 | $-810 | $-330 |